GlaxoSmithKline Pharmaceuticals Ltd.

NSE: GLAXO | BSE: 500660 | ISIN: INE159A01016 | Industry: Pharmaceuticals
| Mid-range Performer
2741.1000 -14.30 (-0.52%)
NSE Sep 19, 2025 15:53 PM
Volume: 85,057
 

logo
GlaxoSmithKline Pharmaceuticals Ltd.
05 Aug 2024
2741.10
-0.52%
buy
by ICICI Securities Limited
Target: 2640
ICICI Securities Limited
GlaxoSmithKline Pharmaceuticals’ (GSK) Q1FY25 result was ahead of our expectations driven by mixed improvement and curb in overhead cost.
 
GlaxoSmithKline Phar.. has an average target of 2800.00 from 2 brokers.
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended
Market closes lower, JSW Energy arm to acquire Tidong Power
Trendlyne Marketwatch | 19 Sep 2025, 03:58PM
Bull run fizzles out: Multibagger count in Indian equities falls
The Baseline | 18 Sep 2025, 03:38PM
From gems to gadgets: India’s $24 billion leap into global smartphone manufacturing
The Baseline | 17 Sep 2025, 06:26PM